---
figid: PMC2732334__nihms-129646-f0001
figlink: /pmc/articles/PMC2732334/figure/F1/
number: Fig. 10.1
caption: 'Ligand binding to inactive monomeric Her receptors is followed by dimer
  formation and kinase activation. Upon recruitment into heterodimers, the ligandless
  coreceptor Her2 enhances and prolongs signaling through several pathways, including
  the indicated mitogen-activated protein kinase (MAPK) pathway and the phosphatidylinositol
  3-kinase (PI3K) route, leading to activation of the Akt/PKB kinase. Points of intervention
  by current drugs targeting Her2 receptors (Herceptin, tyrosine kinase inhibitors)
  are indicated. The abbreviations used are as follows: PDK-1 phosphoinositide-dependent
  kinase 1, TK tyrosine kinase.'
pmcid: PMC2732334
papertitle: Assay for Isolation of Inhibitors of Her2-Kinase Expression.
reftext: Gabriela Chiosis, et al. Methods Mol Biol. ;486:139-149.
pmc_ranked_result_index: '94985'
pathway_score: 0.9588332
filename: nihms-129646-f0001.jpg
figtitle: Ligand binding to inactive monomeric Her receptors is followed by dimer
  formation and kinase activation
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2732334__nihms-129646-f0001.html
  '@type': Dataset
  description: 'Ligand binding to inactive monomeric Her receptors is followed by
    dimer formation and kinase activation. Upon recruitment into heterodimers, the
    ligandless coreceptor Her2 enhances and prolongs signaling through several pathways,
    including the indicated mitogen-activated protein kinase (MAPK) pathway and the
    phosphatidylinositol 3-kinase (PI3K) route, leading to activation of the Akt/PKB
    kinase. Points of intervention by current drugs targeting Her2 receptors (Herceptin,
    tyrosine kinase inhibitors) are indicated. The abbreviations used are as follows:
    PDK-1 phosphoinositide-dependent kinase 1, TK tyrosine kinase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - RAF1
  - PIK3R5
  - AKT1
  - PIK3CD
  - NRAS
  - PIK3R6
  - AKT3
  - ERBB2
  - KRAS
  - PIK3CB
  - AKT2
  - PIK3R3
  - HRAS
  - PDK1
  - PIK3CA
  - PIK3CG
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Raf-1
  symbol: Raf-1
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Her2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PDK-1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
chemicals: []
diseases: []
---
